EAPCI contributed numerous sessions to the ESC Congress 2007 held in Vienna. A list of sessions relevant to Interventional Cardiologists was published prior to the meeting and is still
available.
Association Track Symposia
The EAPCI session discussed the best LIVE cases of EuroPCR Barcelona 2007 and DES Safety and was chaired by J Marco and C Di Mario.
| Topic |
Speaker |
| Structural heart disease |
H Sievert |
| Coronary and peripheral intervention |
A Cremonesi |
| Primary PCI for ST-elevation myocardial infarction: interactive case discussion |
D Dudek |
| Report ESC task force on drug eluting safety |
W Wijns |
 |
View the Association Track webcasts here |
Hot Line and Clinical Trial Update Sessions
Several key sessions, including the Hot Line Sessions are now available. Hot Line II Session and Hot Line III Session were composed of some EAPCI related topics as outlined below.
Hot Line II Session
| Topic |
Speaker |
| Reopro and peripheral arterial intervention to improve clinical outcome in patients with peripheral arterial disease (RIO-Trial) |
I Baumgartner |
| Discussant (RIO-Trial) |
H Sievert |
| The FINESSE Trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). |
S Ellis |
| Discussant (FINESSE) |
F Van de Werf |
| Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction (CARESS in AMI) |
C Di Mario |
| Discussant (CARESS in AMI) |
F Verheugt |
| MICHELANGELO: OASIS 5 Women's substudy |
E Swahn |
| Discussant (MICHELANGELO: OASIS 5 Women's Substudy) |
A Rosengren |
| PRAGUE-8 Study |
P Widimsky |
| Discussant (PRAGUE-8) |
F J Neumann |
|
View the Hot Line II Session webcasts here |
Hot Line III Session
| Topic |
Speaker |
| Excess cardiovascular mortality in patients with peripheral arterial disease in primary care: 5-year results of the getABI study |
C Diehm |
| Discussant (getABI) |
D Poldermans |
| The outcome of PCI for stent-thrombosis multicentre study (OPTIMIST) |
F Burzotta |
| Increased all-cause mortality at 2 year follow-up after PCI with drug-eluting stents vs bare metal stents in acute coronary syndromes: the GRACE registry experience |
P G Steg |
| Discussant (OPTIMIST / GRACE Registry) |
W Wijns |
|
View the Hot Line III Session webcasts here |
State of the Art and Featured Research Sessions
A new feature of ESC Congress 2007 programme was the "State of the Art and Featured Research Sessions" series of lectures. You will find below those directly concerning EAPCI topics.
Congress Reports
The ESC Congress Report team was very active during the meeting and has provided numerous reports on the most relevant trial presentations which we have highlighted below.
HOT LINE AND CLINICAL TRIAL UPDATES SESSIONS REPORTS
| Published date |
Title |
Authors |
Topic |
| 02 September 2007 |
The Danish multicenter randomised study of fibrinolytic therapy versus primary angioplasty in acute myocardial infarction (the DANAMI-2 trial). Outcome after three years follow-up. |
Nielsen, Torsten Toftegaard (Denmark) & Steg, Philippe Gabriel |
Acute Coronary Syndromes (ACS) |
| 02 September 2007 |
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. STEEPLE one year follow-up. |
Montalescot, Gilles (France) & Kristensen, Steen Dalby (Denmark) |
Chronic Ischaemic Heart Disease (IHD) |
| 02 September 2007 |
Enoxaparin versus unfractionated heparin for STEMI: one year results of ExTRACT-TIMI 25 trial. |
Morrow, David (USA) & Wallentin, Lars (Sweden) |
Acute Coronary Syndromes (ACS) |
| 02 September 2007 |
One-year clinical outcomes in the ISAR-REACT 2 trial, a randomised comparison of abciximab versus placebo in patients with non-ST segment elevation acute coronary syndromes undergoing PCI after pretreatment with clopidogrel. |
Seyfarth, Melchior (Germany) |
Acute Coronary Syndromes (ACS) |
| 02 September 2007 |
SCAAR - Long term mortality after drug eluting stents in Sweden, an additional year of follow-up |
James, Stefan (Sweden) |
Chronic Ischaemic Heart Disease (IHD) |
| 03 September 2007 |
OASIS 5: Worse outcome with an invasive strategy among women with non ST-elevation acute coronary syndromes. |
Swahn, Eva (Sweden) & Rosengren, Annika (Sweden)
|
Acute Coronary Syndromes (ACS) |
In addition to these reports on individual trials, there are reports and comments available for some key sessions.
KEY SESSION REPORTS
Opinions/hypothesis expressed in the presentations are those of the authors and not necessarily those of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), a Registered Branch of the ESC.
EAPCI is offering this service as a Congress report but it is not responsible for the scientific content of the presentations.